Champions Oncology, Inc.CSBRNASDAQ
Loading
| Metric | Apr 21 | Apr 22 | Apr 23 |
|---|---|---|---|
| Revenue | 41 | 49 | 54 |
| Gross Profit | 20 | 25 | 24 |
| Operating Income | 0 | 1 | -4 |
| Net Income | 0 | 1 | -5 |
| EBITDA | 2 | 3 | -2 |
| EPS Diluted | 0.02 | 0.04 | -0.39 |
| Metric | Apr 21 | Apr 22 | Apr 23 |
|---|---|---|---|
| Cash & Equivalents | 5 | 9 | 10 |
| Total Current Assets | 13 | 20 | 19 |
| Total Assets | 28 | 35 | 34 |
| Total Current Liabilities | 11 | 17 | 22 |
| Total Liabilities | 20 | 26 | 30 |
| Total Equity | 7 | 9 | 5 |
| Total Debt | 10 | 9 | 9 |
| Net Debt | 5 | 0 | -2 |
| Metric | Apr 21 | Apr 22 | Apr 23 |
|---|---|---|---|
| Operating Cash Flow | -2 | 6 | 4 |
| Capital Expenditure | -3 | -2 | -3 |
| Free Cash Flow | -5 | 4 | 1 |
| Stock-Based Comp | 1 | 1 | 1 |
| Net Change in Cash | -4 | 4 | 1 |